ClinicalTrials.Veeva

Menu

ACT for CP Individual Patient Expanded Access IND Protocol

C

Charles Cox

Status

Conditions

Cerebral Palsy

Treatments

Biological: Autologous Cord Blood Stem Cells

Study type

Expanded Access

Funder types

Other

Identifiers

NCT03203941
HSC-MS-17-0529

Details and patient eligibility

About

Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.

Full description

This protocol is part of an FDA Individual Patient Expanded Access IND submitted at the request of the parents of a child with cerebral palsy (CP) who is ineligible to participate in other stem cell studies. For this child, there are no other treatment options.

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

Exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems